Jinxin Fertility Group Ltd 2022 SR
The report highlights Jinxin Fertility's 2022 performance, including completing 26,125 IVF cycles and achieving an "A" MSCI ESG rating. The company focused on discipline construction, scientific innovation, and digital hospital transformation to enhance patient services. Key achievements include the acquisition of Jiuzhou and Hewanjia Hospitals and a 28.6% revenue increase. Environmental efforts led to reductions in greenhouse gas emissions and water consumption per unit of revenue. The group also emphasized employee development, achieving a 97% training coverage rate.
Company: Jinxin Fertility Group Ltd
Sector: Healthcare & social services
Country: China
Year: 2022
Type: SR
Pages: 44
Jinxin Fertility Group Ltd
The report highlights Jinxin Fertility's 2022 performance, including completing 26,125 IVF cycles and achieving an "A" MSCI ESG rating. The company focused on discipline construction, scientific innovation, and digital hospital transformation to enhance patient services. Key achievements include the acquisition of Jiuzhou and Hewanjia Hospitals and a 28.6% revenue increase. Environmental efforts led to reductions in greenhouse gas emissions and water consumption per unit of revenue. The group also emphasized employee development, achieving a 97% training coverage rate.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Apr 18, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees